Multiple Sclerosis, Relapsing-Remitting Clinical Trials in Chicago, Illinois
3 recruitingChicago, Illinois
Showing 1–3 of 3 trials
Recruiting
Phase 3
Study to Evaluate the Effectiveness and Safety of Ozanimod Compared to Fingolimod in Children and Adolescents With Relapsing Remitting Multiple Sclerosis
Multiple Sclerosis, Relapsing-Remitting
Bristol-Myers Squibb194 enrolled33 locationsNCT06408259
Recruiting
Not Applicable
Effects of Acute Intermittent Hypoxia on Neuroplasticity in MS
Multiple SclerosisMultiple Sclerosis, Relapsing-RemittingMultiple Sclerosis, Secondary Progressive
Shirley Ryan AbilityLab22 enrolled1 locationNCT06390930
Recruiting
Development of Camera Based Gait Quality Measure for Persons With Multiple Sclerosis
Multiple SclerosisMultiple Sclerosis, Relapsing-RemittingMultiple Sclerosis, Secondary Progressive+1 more
Shirley Ryan AbilityLab40 enrolled1 locationNCT06516458